BLENOXANE(BLEOMYCIN SULFATE) - 美国FDA药品数据库

药品名称	BLENOXANE
申请号	050443	产品号	001
活性成分	BLEOMYCIN SULFATE	市场状态	停止上市
剂型或给药途径	INJECTABLE;INJECTION	规格	EQ 15 UNITS BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons
治疗等效代码		参比药物	否
批准日期	Approved Prior to Jan 1, 1982	申请机构	BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
化学类型	New molecular entity (NME)	审评分类

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
050443	036	AP	2010/05/10	Labeling Revision
050443	035	AP	2003/03/21	Labeling Revision
050443	033	AP	2002/03/20	Manufacturing Change or Addition
050443	032	AP	2000/07/03	Manufacturing Change or Addition
050443	031	AP	2000/04/12	Package Change
050443	030	AP	2000/07/03	Manufacturing Change or Addition
050443	029	AP	1999/10/20	Labeling Revision
050443	028	AP	1999/08/25	Labeling Revision
050443	027	AP	2004/06/30	Labeling Revision
050443	026	AP	1996/09/30	Manufacturing Change or Addition
050443	025	AP	1996/02/20	New or Modified Indication
050443	024	AP	1995/09/07	Manufacturing Change or Addition
050443	023	AP	1993/02/23	Labeling Revision
050443	022	AP	1994/01/21	Control Supplement
050443	021	AP	1994/01/21	Manufacturing Change or Addition
050443	020	AP	1991/01/30	Control Supplement
050443	019	AP	1994/01/21	Control Supplement
050443	017	AP	1994/01/21	Control Supplement
050443	014	AP	1983/10/21	Control Supplement
050443	013	AP	1983/10/19	Expiration Date Change
050443	012	AP	1983/09/26	Control Supplement
050443	011	AP	1983/04/13	Labeling Revision
050443	010	AP	1982/12/13	Control Supplement
050443	009	AP	1976/12/21	Labeling Revision
050443	008	AP	1976/03/15	Labeling Revision
050443	007	AP	1976/03/31	Control Supplement
050443	006	AP	1975/10/10	Control Supplement
050443	005	AP	1976/04/05	Expiration Date Change
050443	004	AP	1975/10/08	Labeling Revision
050443	003	AP	1975/03/05	Control Supplement
050443	002	AP	1974/08/09	Labeling Revision
050443	000	AP	1973/07/31	Approval